The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 5, Pages 1206
Publisher
MDPI AG
Online
2020-05-14
DOI
10.3390/cells9051206
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
- (2020) Marc Rigau et al. SCIENCE
- Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing
- (2020) Mohindar M. Karunakaran et al. IMMUNITY
- Human γδ TCR Repertoires in Health and Disease
- (2020) Alina Suzann Fichtner et al. Cells
- Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
- (2019) Mohammed Alnaggar et al. Journal for ImmunoTherapy of Cancer
- Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells
- (2019) Biagio Di Lorenzo et al. Cancer Immunology Research
- Mechanisms of resistance to CAR T cell therapy
- (2019) Nirali N. Shah et al. Nature Reviews Clinical Oncology
- A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation
- (2019) Yunyun Yang et al. IMMUNITY
- The IL-17 Family of Cytokines in Health and Disease
- (2019) Mandy J. McGeachy et al. IMMUNITY
- Vitamin C promotes the proliferation and effector functions of human γδ T cells
- (2019) Léonce Kouakanou et al. Cellular & Molecular Immunology
- Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies
- (2019) Zsolt Sebestyen et al. NATURE REVIEWS DRUG DISCOVERY
- An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer
- (2019) Yin Wu et al. Science Translational Medicine
- Tim-3 suppresses the killing effect of Vγ9Vδ2 T cells on colon cancer cells by reducing perforin and granzyme B expression
- (2019) Xiaomi Li et al. EXPERIMENTAL CELL RESEARCH
- Mechanistic insights into cancer immunity and immunotherapy
- (2018) Weiping Zou Cellular & Molecular Immunology
- TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
- (2018) Lan Huang et al. Cellular & Molecular Immunology
- Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells
- (2018) Xiaoqing Zhang et al. Cellular & Molecular Immunology
- Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment
- (2018) Ganjun Yu et al. Cellular & Molecular Immunology
- Emerging predictors of the response to the blockade of immune checkpoints in cancer therapy
- (2018) Xiaolei Li et al. Cellular & Molecular Immunology
- NKG2D and its ligands in cancer
- (2018) Payal Dhar et al. CURRENT OPINION IN IMMUNOLOGY
- IL-21 Increases the Reactivity of Allogeneic Human Vγ9Vδ2 T Cells Against Primary Glioblastoma Tumors
- (2018) Noémie Joalland et al. JOURNAL OF IMMUNOTHERAPY
- Gamma-delta (γδ) T cells: friend or foe in cancer development?
- (2018) Yijing Zhao et al. Journal of Translational Medicine
- Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation
- (2018) Anna Capsomidis et al. MOLECULAR THERAPY
- Epithelial damage and tissue γδ T cells promote a unique tumor-protective IgE response
- (2018) Greg Crawford et al. NATURE IMMUNOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- The human Vδ2+ T-cell compartment comprises distinct innate-like Vγ9+ and adaptive Vγ9- subsets
- (2018) Martin S. Davey et al. Nature Communications
- Working in “NK Mode”: Natural Killer Group 2 Member D and Natural Cytotoxicity Receptors in Stress-Surveillance by γδ T Cells
- (2018) Bruno Silva-Santos et al. Frontiers in Immunology
- GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
- (2018) Trudy Straetemans et al. Frontiers in Immunology
- Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells
- (2018) Hans H. Oberg et al. Frontiers in Immunology
- Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model
- (2018) Maaike V. J. Braham et al. OncoImmunology
- γδ T cells control humoral immune response by inducing T follicular helper cell differentiation
- (2018) Rafael M. Rezende et al. Nature Communications
- Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma
- (2018) Cédric Rossi et al. OncoImmunology
- The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region
- (2017) Khiem Nguyen et al. FASEB JOURNAL
- The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells
- (2017) Cassie-Marie Peigné et al. JOURNAL OF IMMUNOLOGY
- Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor
- (2017) Jonathan Fisher et al. MOLECULAR THERAPY
- Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation
- (2017) Siyi Gu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity
- (2017) Guranda Chitadze et al. TRENDS IN IMMUNOLOGY
- Current Advances in γδ T Cell-Based Tumor Immunotherapy
- (2017) Elena Lo Presti et al. Frontiers in Immunology
- A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells
- (2017) Renée C. G. de Bruin et al. OncoImmunology
- Driving gene-engineered T cell immunotherapy of cancer
- (2016) Laura A Johnson et al. CELL RESEARCH
- Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept
- (2016) A. R. Almeida et al. CLINICAL CANCER RESEARCH
- Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
- (2016) Heleen H. Van Acker et al. Journal of Hematology & Oncology
- In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma
- (2016) Joseph G. Pressey et al. MEDICINE
- Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity
- (2015) Masato Muto et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- γδ T cell activation by bispecific antibodies
- (2015) Hans-Heinrich Oberg et al. CELLULAR IMMUNOLOGY
- Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy
- (2015) Heleen H Van Acker et al. OncoImmunology
- Ex vivoexpanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer
- (2015) Dang Wu et al. OncoImmunology
- γδT Cells: First Line of Defense and Beyond
- (2014) Yueh-hsiu Chien et al. Annual Review of Immunology
- Novel Bispecific Antibodies Increase T-Cell Cytotoxicity against Pancreatic Cancer Cells
- (2014) H.-H. Oberg et al. CANCER RESEARCH
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
- (2014) Andrew Sandstrom et al. IMMUNITY
- γδ T Cells and Their Potential for Immunotherapy
- (2014) Yan-Ling Wu et al. International Journal of Biological Sciences
- Cytotoxic and Regulatory Properties of Circulating Vδ1+ γδ T Cells: A New Player on the Cell Therapy Field?
- (2014) Gabrielle M Siegers et al. MOLECULAR THERAPY
- γδ T cell surveillance via CD1 molecules
- (2014) Adrienne M. Luoma et al. TRENDS IN IMMUNOLOGY
- Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
- (2014) Ikuo Wada et al. Cancer Medicine
- Tumor-ActivatedTCRγδ+T Cells from Gastric Cancer Patients Induce the Antitumor Immune Response ofTCRαβ+T Cells via Their Antigen-Presenting Cell-Like Effects
- (2014) Chaoming Mao et al. Journal of Immunology Research
- γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy
- (2014) Alessandro Poggi et al. Frontiers in Immunology
- Plasticity of γδ T Cells: Impact on the Anti-Tumor Response
- (2014) Virginie Lafont et al. Frontiers in Immunology
- Clinical Applications of Gamma Delta T Cells with Multivalent Immunity
- (2014) Drew C. Deniger et al. Frontiers in Immunology
- Specific tumor targeting and activation of Vγ9Vδ2 T cells by bi-specific nanobodies
- (2014) Anita Stam et al. Journal for ImmunoTherapy of Cancer
- Anti-metastatic potential of human Vδ1+ γδ T cells in an orthotopic mouse xenograft model of colon carcinoma
- (2013) Christel Devaud et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells
- (2013) Daofeng Liu et al. CLINICAL IMMUNOLOGY
- Crystal Structure of Vδ1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T Cells
- (2013) Adrienne M. Luoma et al. IMMUNITY
- Cutting Edge: CD1d Restriction and Th1/Th2/Th17 Cytokine Secretion by Human V 3 T Cells
- (2013) B. A. Mangan et al. JOURNAL OF IMMUNOLOGY
- Tumor-Derived Regulatory T Cells Suppress Innate and Adaptive Immunity through the Induction of Immunosenescence
- (2013) J. Ye et al. JOURNAL OF IMMUNOLOGY
- Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor
- (2013) Drew C Deniger et al. MOLECULAR THERAPY
- Mechanisms of the Antitumor Activity of Human Vγ9Vδ2 T Cells in Combination With Zoledronic Acid in a Preclinical Model of Neuroblastoma
- (2013) Emma Di Carlo et al. MOLECULAR THERAPY
- Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
- (2013) Stefano Vavassori et al. NATURE IMMUNOLOGY
- Natural Cytotoxicity Receptors: Broader Expression Patterns and Functions in Innate and Adaptive Immune Cells
- (2013) Kelly Hudspeth et al. Frontiers in Immunology
- Tumor cell recognition by γδ T lymphocytes
- (2013) Daniel V. Correia et al. OncoImmunology
- 9 and 2CDR3 domains regulate functional avidity of T cells harboring 9 2TCRs
- (2012) C. Grunder et al. BLOOD
- CD277 takes the lead in human T-cell activation
- (2012) D. Kabelitz BLOOD
- Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells
- (2012) Andrea Knight et al. CYTOTHERAPY
- The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR
- (2012) Li Bai et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Understanding the complexity of γδ T-cell subsets in mouse and human
- (2012) Dick J. Pang et al. IMMUNOLOGY
- Human cord blood γδ T cells expressing public Vγ2 chains dominate the response to bisphosphonate plus interleukin-15
- (2012) Cristiana Cairo et al. IMMUNOLOGY
- Human V 9V 2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts
- (2012) J. Gertner-Dardenne et al. JOURNAL OF IMMUNOLOGY
- Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy
- (2012) Volker Kunzmann et al. JOURNAL OF IMMUNOTHERAPY
- Phenotypic and Functional Characterization of Human γδ T-Cell Subsets in Response to Influenza A Viruses
- (2012) Gang Qin et al. JOURNAL OF INFECTIOUS DISEASES
- EPCR: a stress trigger for γδ T cells
- (2012) Deborah A Witherden et al. NATURE IMMUNOLOGY
- Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor
- (2012) Carrie R Willcox et al. NATURE IMMUNOLOGY
- Redirecting T cells against cancer cells by transfer of a broadly tumor-reactive T-cell receptor
- (2011) V. Marcu-Malina et al. BLOOD
- Differentiation of human peripheral blood V 1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells
- (2011) D. V. Correia et al. BLOOD
- Differentiation, phenotype, and function of interleukin-17-producing human V 9V 2 T cells
- (2011) N. Caccamo et al. BLOOD
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
- (2011) Hirohito Kobayashi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
- (2011) Joshua M. Lang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Harnessing natural killer T (NKT) cells in human myeloma: Progress and challenges
- (2011) Madhav V. Dhodapkar et al. CLINICAL IMMUNOLOGY
- Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells
- (2011) Gabrielle M. Siegers et al. CYTOTHERAPY
- IL-21 enhances the potential of human γδ T cells to provide B-cell help
- (2011) Raj R. Bansal et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Stimulated T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer
- (2011) A.-H. Capietto et al. JOURNAL OF IMMUNOLOGY
- Adoptive Immunotherapy for Advanced Non-small CellLung Cancer Using Zoledronate-expanded γδTCells
- (2011) Miki Sakamoto et al. JOURNAL OF IMMUNOTHERAPY
- Sensitization of human osteosarcoma cells to Vγ9Vδ2 T-cell-mediated cytotoxicity by zoledronate
- (2011) Zhaoxu Li et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Crystal structure of a T-cell receptor specific for the human MHC class I homolog MICA
- (2011) B. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Longevity and Composition of Cellular Immune Responses Following Experimental Plasmodium falciparum Malaria Infection in Humans
- (2011) Anne C. Teirlinck et al. PLoS Pathogens
- Human T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement
- (2010) A. Maniar et al. BLOOD
- Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
- (2010) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells☆☆☆
- (2010) Jun Nakajima et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
- (2010) Ying Liu et al. Molecular Cancer
- Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide
- (2010) Michael Nowak et al. PLoS One
- Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies
- (2009) J. Gertner-Dardenne et al. BLOOD
- DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells
- (2009) Olivier Toutirais et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
- (2009) Yu Abe et al. EXPERIMENTAL HEMATOLOGY
- Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
- (2008) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Microbial Flora Drives Interleukin 22 Production in Intestinal NKp46+ Cells that Provide Innate Mucosal Immune Defense
- (2008) Naoko Satoh-Takayama et al. IMMUNITY
- Vγ9Vδ2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs—Rituximab and trastuzumab
- (2008) Hirotake Tokuyama et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More